Caplin Point Laboratories Limited logo

Caplin Point Laboratories Limited

NSE:CAPLIPOINT.NS

Overview | Financials
Company Name Caplin Point Laboratories Limited
Symbol CAPLIPOINT.NS
Currency INR
Price 1,958.8
Market Cap 148,891,717,960
Dividend Yield 0.33%
52-week-range 954 - 2,158.8
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Sridhar Ganesan
Website https://www.caplinpoint.net

An error occurred while fetching data.

About Caplin Point Laboratories Limited

Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhalers, IV infusions, lyophilized products, branded products, dermo cosmetics,

Related Stocks

Sun Pharma Advanced Research Company Limited logo

Sun Pharma Advanced Research Company Limited

SPARC.NS

224.57 INR

Glenmark Life Sciences Limited logo

Glenmark Life Sciences Limited

GLS.NS

1,310.9 INR

Hikal Limited logo

Hikal Limited

HIKAL.NS

383.8 INR

Granules India Limited logo

Granules India Limited

GRANULES.NS

549.9 INR

Jubilant Pharmova Limited logo

Jubilant Pharmova Limited

JUBLPHARMA.NS

1,224.2 INR

AstraZeneca Pharma India Limited logo

AstraZeneca Pharma India Limited

ASTRAZEN.NS

6,747.35 INR

Poly Medicure Limited logo

Poly Medicure Limited

POLYMED.NS

2,449.35 INR

FDC Limited logo

FDC Limited

FDC.NS

579.5 INR

Vijaya Diagnostic Centre Limited logo

Vijaya Diagnostic Centre Limited

VIJAYA.NS

918.4 INR

Procter & Gamble Health Limited logo

Procter & Gamble Health Limited

PGHL.NS

5,158.45 INR

Financials

Numbers are in millions USD

Numbers are in millions USD